Catalyst

Slingshot members are tracking this event:

Celgene Settles REVLIMID Patent Litigation with Natco Pharma Ltd. of India, Natco's U.S. partner, Arrow International Limited, and Arrow's parent company, Watson Laboratories, Inc. (a wholly-owned subsidiary of Allergan plc)

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
CELG

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 22, 2015
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Revlimid, Patent, Litigation, Settlement, Lenalidomide